Nabla, a leading AI assistant for clinical care, announced on June 17, 2025, a $70 million Series C funding round led by HV Capital, with participation from Highland Europe, DST Global, Cathay Innovation, and Tony Fadell’s Build Collective. This brings Nabla’s total funding to $120 million, accelerating its mission to streamline clinical and financial workflows through advanced AI.
Nabla raises $70M Series C, totaling $120M in funding.
Supports 85,000+ clinicians across 130+ U.S. healthcare organizations.
Revenue grew fivefold in the past six months.
Expands AI assistant for coding, EHR actions, and diverse clinical roles.
Integrates with Epic, Cerner, athenahealth, and other major EHRs.
Cuts documentation time by over 50%, boosting patient satisfaction.
Nabla’s AI assistant, used by over 85,000 clinicians in settings like ambulatory, pediatric, and emergency care, is expanding into inpatient and nursing workflows. “We’re going even deeper into clinical workflows while continuing to offer a highly customizable assistant that works across specialties,” said Alex Lebrun, co-founder and CEO of Nabla. The platform reduces documentation time by more than half, with studies from University of Iowa Health Care and Denver Health showing reduced clinician burnout and a 15-point increase in patient satisfaction.
The $70M will fund Nabla’s Adaptive Agentic Platform, introducing:
Proactive Coding Agent: Enhances real-time ICD-10, HCC, and E/M coding support.
Context-Aware Agent: Uses historical data for smarter documentation and EHR commands.
Custom Care Setting Agent: Tailors tools for nurses and inpatient teams.
Nabla processes over 30 billion tokens monthly, ensuring continuous refinement. Its privacy-first model, compliance with HIPAA and GDPR, and membership in the Coalition for Health AI reinforce trust. The platform’s integration with major EHRs like Epic and Cerner drives adoption across 130+ organizations, including CVS Health and Children’s Hospital Los Angeles.
“Nabla stands out as a pioneer in clinical AI—not just for its bold vision, but for its enterprise-grade product and remarkable speed of execution,” said Alexander Joel-Carbonell, Partner at HV Capital. Dr. James Blum from University of Iowa Physicians praised Nabla’s seamless Epic integration and rapid adoption, noting, “Nabla listens, adapts, and builds with us.” With fivefold revenue growth in six months and support for 20 million annual encounters in 35 languages, Nabla is poised to transform healthcare delivery nationwide.
Nabla’s Series C funding empowers its vision of an intuitive AI assistant that not only documents care but actively enhances clinical efficiency, restoring the human connection in healthcare.
Nabla is on a mission to restore the human connection at the heart of healthcare through industry-leading clinical AI that optimizes clinical and financial workflows. Its assistant helps clinicians generate high-quality notes in seconds through ambient documentation, dictation, and real-time coding support. Nabla integrates with all major EHRs, supports more than 35 languages, and is used across over 130 health systems and provider groups.
The company is evolving into an adaptive agentic platform that supports a wider range of clinical workflows, care settings, and provider roles, empowering clinicians to dedicate more time to patient care.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.